Predictors of stroke risk in native Chinese with nonrheumatic atrial fibrillation: Retrospective investigation of hospitalized patients

Clinical Cardiology

Volumn 32, Issue 2, 2009, Pages 76-81

  Sun, Yihong ^a   Hu, Dayi ^a   Li, Kuibao ^a   Zhou, Ziqiang ^b  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Atrial fibrillation; Risk factor; Stroke; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ADULT; AGED; ARTICLE; CHINA; CONFIDENCE INTERVAL; ETHNOLOGY; FEMALE; HEART ATRIUM FIBRILLATION; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; RISK; RISK FACTOR; STATISTICAL MODEL; STROKE;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; CHINA; CONFIDENCE INTERVALS; FEMALE; HOSPITALIZATION; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; WARFARIN;

EID: 70349921226     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20232     Document Type: Article

References (16)

1. Wolf PA, Abbott RD, Kannel WB: Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991;22:983-988
2. Hart RG, Benavente O, McBride R, Pearce LA: Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis. Ann Intern Med 1999;1(31):492-501 (Pubitemid 29482392)
3. Wen-Hang QI, Society of Cardiology, Chinese Medical Association: Retrospective investigation of hospitalised patients with atrial fibrillation in mainland China. Int J Cardiol 2005;105(3):283-287 (Pubitemid 41605077)
4. He J, Gu D, Wu X, Reynolds K, Duan X, et al.: Major causes of death among men and women in China. NEngl J Med 2005;353(11):1124-1134 (Pubitemid 41317435)
5. Report of the WHO task force on stroke and other cerebrovascular disorders: Stroke-1989: recommendations on stroke prevention, diagnosis, and therapy. Stroke 1989;20:1407-1431
6. Hart RG, Pearce LA, McBride R, Rothbart RM, Asinger RW, Stroke Prevention in Atrial Fibrillation (SPAF) Investigators: Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. Stroke 1999;30:1223-1229 (Pubitemid 29259178)
7. Brignole M, Gianfranchi L, Menozzi C, Alboni P, Musso G, et al.: Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation: a randomized controlled study. Circulation 1997;96:2617-2624 (Pubitemid 27451354)
8. Fihn SD, Callahan CM, Martin DC, McDonell MB, Henikoff JG, et al., National Consortium of Anticoagulation Clinics: The risk for and severity of bleeding complications in elderly patients treated with warfarin. Ann Intern Med 1996;124:970-979
9. Stroke prevention in atrial fibrillation committee on echocardiography: Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with atrial fibrillation. Ann Intern Med 1998;128:639-647
10. The AFFIRM Investigators: A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;34:1825-1833
11. Aschenberg W, Schluter M, Kremer P, Schroder E, Siglow V, et al.: Transesophageal two-dimensional echocardiography for the detection of left atrial appendage thrombus. J Am Coll Cardiol 1986;7:163-166 (Pubitemid 16132471)
12. The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators: Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. JAMA 1998;279:1273-1277
13. AF Investigators: Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-1457
14. Go AS, Hylek EM, Phillips KA, Borowsky LH, Henault LE, et al.: Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. Circulation 2000;102(1):11-13 (Pubitemid 30430546)
15. Nieuwlaat R, Capucci A, Camm AJ, Olsson SB, Andresen D, et al., European Heart Survey Investigators: Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. Eur Heart J 2005;26(22):2422-2434 (Pubitemid 41552972)
16. Leung CS, Tam KM: Antithrombotic treatment of atrial fibrillation in a regional hospital in Hong Kong. Hong Kong Med J 2003;9(3):179-185 (Pubitemid 36644582)